Researchers devise effective prediction model for diagnosing thoracic aorta aneurysms: JAMA Jacinthlyn Sylvia22 Nov 2022 8:00 PM ISTTo forecast ascending aortic diameter, a prediction model based on typical clinically accessible data was developed and validated. This study was...
Long COVID-19 symptoms similar in hospitalized and nonhospitalized patients 2 years after infection: JAMA Dr. Kamal Kant Kohli17 Nov 2022 12:00 PM ISTSPAIN: The COVID-19 virus has altered the course of history during the past two years. Further most significant observation is the emergence or...
Longer intervals between hemodialysis and surgery may increase risk of postoperative mortality in CKD: JAMA Jacinthlyn Sylvia13 Nov 2022 8:00 PM ISTA new study published in the Journal of American Medical Association shows that longer intervals between hemodialysis and surgery were substantially...
Spinal cord burst stimulation fails to improve back pain-related disability following lumbar spine surgery Dr. Kamal Kant Kohli9 Nov 2022 8:00 PM ISTNORWAY: Researchers have found in a new study that Spinal cord burst stimulation fails to improve back pain-related disability following lumbar spine...
ECMO use linked to increased risk of mental health and social issues: JAMA Jacinthlyn Sylvia1 Nov 2022 7:30 PM ISTA new study published in the Journal of American Medical Association suggests that receiving extracorporeal membrane oxygenation (ECMO) in comparison...
High-flow nasal cannula for COVID-19 respiratory failure doesn't reduce fatalities: SOHO Trial Dr. Kamal Kant Kohli15 Oct 2022 12:30 PM ISTFRANCE: According to a study published in JAMA Network, high-flow nasal cannula (HFNC) oxygen administration did not lower mortality among critically...
Cefepime/enmetazobactam combo bests piperacillin/tazobactam for severe UTI treatment: JAMA Jacinthlyn Sylvia6 Oct 2022 7:48 PM ISTA new study published in the Journal of American Medical Association found that, cefepime/enmetazobactam was well superior to piperacillin/tazobactam...
COVID booster significantly improves protection against Omicron hospitalization: JAMA Dr. Kamal Kant Kohli3 Oct 2022 6:00 PM ISTCHICAGO: A US case-control research published in JAMA Network shows that, three doses of an mRNA COVID-19 vaccination were associated with a 59% lower...
Use of SGLT2 inhibitors reduces risk of dry eye disease: JAMA Dr. Kamal Kant Kohli27 Sept 2022 7:30 PM ISTTAIWAN: According to the researchers of a large retrospective study reported in JAMA Network Open, one advantage of SGLT2 inhibitors in people with...
Roflumilast cream effective for treating plaque psoriasis: JAMA Dr. Kamal Kant Kohli26 Sept 2022 7:30 PM ISTUSA: According to a study published in JAMA Network, roflumilast cream was effective in treating plaque psoriasis in patients after 8 weeks of...
JAMA study finds no difference in incident CVD events among women and men with type 1 diabetes Dr. Kamal Kant Kohli11 Sept 2022 8:00 PM ISTUSA: Despite having a more favorable cardiometabolic risk factor profile than men, the incidence of CVD events was not significantly lower in women...
Statins improve limb salvage and CV risk in renal failure patients with PAD on dialysis: JAMA Dr. Kamal Kant Kohli5 Sept 2022 11:00 AM ISTTAIWAN: Patients on long-term maintenance dialysis with concurrent PAD and renal failure may benefit from statin medication in terms of protecting...
